Company Filing History:
Years Active: 2004-2013
Title: The Innovative Contributions of Howard Robert Marshall
Introduction
Howard Robert Marshall, an inventor based in Harlow, GB, has made significant strides in the field of pharmaceuticals with his focus on nicotinic acetylcholine receptors. With a total of three patents to his name, Marshall's work exemplifies the intersection of science and innovation.
Latest Patents
Among his latest patents, Marshall has developed innovative compounds that serve as modulators of the α7 nicotinic acetylcholine receptor (nAChR). One notable patent describes a compound named N-[(2-Trifluoromethyl-1H-indol-5-yl)methyl]-2-(trifluoromethyl)-5-pyrimidinecarboxamide, which offers advancements in the modulation of receptor activity. His second patent also focuses on indole modulators that impact the α7 nAChR, embodying inventive approaches to potentially enhance therapeutic applications.
Career Highlights
Throughout his career, Howard Robert Marshall has contributed to renowned companies such as Proximagen Limited and SmithKline Beecham Corporation. His work at these institutions has been pivotal in developing innovative solutions within the pharmaceutical landscape.
Collaborations
In his journey as an inventor, Marshall has collaborated with notable colleagues, including Kevin Dinnell and Andrew Lightfoot. These collaborations highlight the importance of teamwork in driving forward groundbreaking innovations.
Conclusion
Howard Robert Marshall's dedication to innovation in the field of pharmaceuticals is evidenced by his patent portfolio and collaborative efforts. His work not only advances the understanding of nicotinic acetylcholine receptors but also contributes to the broader landscape of medical research and development.